| Predicate |
Object |
| contentType |
Introductory Journal Article |
| endingPage |
87 |
| issn |
1744-7658
1354-3784 |
| issueIdentifier |
2 |
| pageRange |
87-87 |
| publicationName |
Expert Opinion on Investigational Drugs |
| startingPage |
87 |
| bibliographicCitation |
Alkhouri N. NASH and NAFLD: emerging drugs, therapeutic targets and translational and clinical challenges. Expert Opinion on Investigational Drugs. 2020 Jan 29;29(2):87. doi: 10.1080/13543784.2020.1721169. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c2496b2f1378c931c4b1b3526d1f7f1 |
| date |
2020-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/31984804
https://doi.org/10.1080/13543784.2020.1721169 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1744-7658
https://portal.issn.org/resource/ISSN/1354-3784
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21889 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
NASH and NAFLD: emerging drugs, therapeutic targets and translational and clinical challenges |
| discusses |
http://id.nlm.nih.gov/mesh/M0023868 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000076722
http://id.nlm.nih.gov/mesh/D065626Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D015507Q000494
http://id.nlm.nih.gov/mesh/D065626Q000503 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11475
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7708 |